Review



biotinylated rabbit anti-rat igg antibody, mouse adsorbed  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Laboratories biotinylated rabbit anti-rat igg antibody, mouse adsorbed
    Biotinylated Rabbit Anti Rat Igg Antibody, Mouse Adsorbed, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1292 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/Biotinylated+Rabbit+Anti-Rat+IgG+Antibody%2C+mouse+adsorbed/custom%40ba-4001%4042564426
    Average 96 stars, based on 1292 article reviews
    biotinylated rabbit anti-rat igg antibody, mouse adsorbed - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    Avidin-Biotin Assay:

    Article Title: Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential
    Article Snippet: To visualise the immunohistochemical, staining the avidin-biotin complex method was utilised, using the guidance manual, biotinylated antibodies, blocking serum, and peroxidase from the VECTASTAIN® Universal Elite® ABC and VECTOR® NovaRedTM peroxidase substrate kits (all Vector Laboratories, Burlingame, CA, USA).

    Article Title: Sterile Production of Interferons in the Thymus Impacts T Cell Repertoire Selection
    Article Snippet: For samples using biotinylated antibodies, samples were blocked with the Avidin/Biotin blocking kit following manufacturer protocol (Vector Laboratories).

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Exploring macrophage differentiation and its relation to Modic changes in human herniated disc tissue
    Article Snippet: Subsequently, an avidin-biotin complex technique was performed with the Vectastain ABC-Elite Kit (Vector Lab. USA) and the appropriate biotinylated antibodies.

    Article Title: Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma
    Article Snippet: They were then treated with their respective biotinylated antibodies, namely anti-mouse IgG or anti-rabbit IgG (1:200; Vector) for 30 minutes at 25°C, followed by treatment with avidin-biotin peroxidase complex for 30 minutes at 25°C.

    Article Title: Modulation of GABAergic System in a Chicken Retinal Ischemic Model: The Role of Chloride Cotransporters
    Article Snippet: Anti‐rabbit (cat# BA‐1000, RRID:AB_2313606) and anti‐goat (cat# BA‐5000, RRID:AB_2336126) biotinylated antibodies, and Vectastain Elite ABC‐HRP kit were obtained from Vector Laboratories (Burlingame, CA, USA).

    Blocking Assay:

    Article Title: Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential
    Article Snippet: To visualise the immunohistochemical, staining the avidin-biotin complex method was utilised, using the guidance manual, biotinylated antibodies, blocking serum, and peroxidase from the VECTASTAIN® Universal Elite® ABC and VECTOR® NovaRedTM peroxidase substrate kits (all Vector Laboratories, Burlingame, CA, USA).

    Article Title: Sterile Production of Interferons in the Thymus Impacts T Cell Repertoire Selection
    Article Snippet: For samples using biotinylated antibodies, samples were blocked with the Avidin/Biotin blocking kit following manufacturer protocol (Vector Laboratories).

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Exploring macrophage differentiation and its relation to Modic changes in human herniated disc tissue
    Article Snippet: Subsequently, an avidin-biotin complex technique was performed with the Vectastain ABC-Elite Kit (Vector Lab. USA) and the appropriate biotinylated antibodies.

    Article Title: Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma
    Article Snippet: They were then treated with their respective biotinylated antibodies, namely anti-mouse IgG or anti-rabbit IgG (1:200; Vector) for 30 minutes at 25°C, followed by treatment with avidin-biotin peroxidase complex for 30 minutes at 25°C.

    Article Title: Modulation of GABAergic System in a Chicken Retinal Ischemic Model: The Role of Chloride Cotransporters
    Article Snippet: Anti‐rabbit (cat# BA‐1000, RRID:AB_2313606) and anti‐goat (cat# BA‐5000, RRID:AB_2336126) biotinylated antibodies, and Vectastain Elite ABC‐HRP kit were obtained from Vector Laboratories (Burlingame, CA, USA).

    Immunohistochemical staining:

    Article Title: Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential
    Article Snippet: To visualise the immunohistochemical, staining the avidin-biotin complex method was utilised, using the guidance manual, biotinylated antibodies, blocking serum, and peroxidase from the VECTASTAIN® Universal Elite® ABC and VECTOR® NovaRedTM peroxidase substrate kits (all Vector Laboratories, Burlingame, CA, USA).

    Article Title: Sterile Production of Interferons in the Thymus Impacts T Cell Repertoire Selection
    Article Snippet: For samples using biotinylated antibodies, samples were blocked with the Avidin/Biotin blocking kit following manufacturer protocol (Vector Laboratories).

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Exploring macrophage differentiation and its relation to Modic changes in human herniated disc tissue
    Article Snippet: Subsequently, an avidin-biotin complex technique was performed with the Vectastain ABC-Elite Kit (Vector Lab. USA) and the appropriate biotinylated antibodies.

    Article Title: Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma
    Article Snippet: They were then treated with their respective biotinylated antibodies, namely anti-mouse IgG or anti-rabbit IgG (1:200; Vector) for 30 minutes at 25°C, followed by treatment with avidin-biotin peroxidase complex for 30 minutes at 25°C.

    Article Title: Modulation of GABAergic System in a Chicken Retinal Ischemic Model: The Role of Chloride Cotransporters
    Article Snippet: Anti‐rabbit (cat# BA‐1000, RRID:AB_2313606) and anti‐goat (cat# BA‐5000, RRID:AB_2336126) biotinylated antibodies, and Vectastain Elite ABC‐HRP kit were obtained from Vector Laboratories (Burlingame, CA, USA).

    Staining:

    Article Title: Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential
    Article Snippet: To visualise the immunohistochemical, staining the avidin-biotin complex method was utilised, using the guidance manual, biotinylated antibodies, blocking serum, and peroxidase from the VECTASTAIN® Universal Elite® ABC and VECTOR® NovaRedTM peroxidase substrate kits (all Vector Laboratories, Burlingame, CA, USA).

    Article Title: Sterile Production of Interferons in the Thymus Impacts T Cell Repertoire Selection
    Article Snippet: For samples using biotinylated antibodies, samples were blocked with the Avidin/Biotin blocking kit following manufacturer protocol (Vector Laboratories).

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Exploring macrophage differentiation and its relation to Modic changes in human herniated disc tissue
    Article Snippet: Subsequently, an avidin-biotin complex technique was performed with the Vectastain ABC-Elite Kit (Vector Lab. USA) and the appropriate biotinylated antibodies.

    Article Title: Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma
    Article Snippet: They were then treated with their respective biotinylated antibodies, namely anti-mouse IgG or anti-rabbit IgG (1:200; Vector) for 30 minutes at 25°C, followed by treatment with avidin-biotin peroxidase complex for 30 minutes at 25°C.

    Article Title: Modulation of GABAergic System in a Chicken Retinal Ischemic Model: The Role of Chloride Cotransporters
    Article Snippet: Anti‐rabbit (cat# BA‐1000, RRID:AB_2313606) and anti‐goat (cat# BA‐5000, RRID:AB_2336126) biotinylated antibodies, and Vectastain Elite ABC‐HRP kit were obtained from Vector Laboratories (Burlingame, CA, USA).

    Plasmid Preparation:

    Article Title: Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential
    Article Snippet: To visualise the immunohistochemical, staining the avidin-biotin complex method was utilised, using the guidance manual, biotinylated antibodies, blocking serum, and peroxidase from the VECTASTAIN® Universal Elite® ABC and VECTOR® NovaRedTM peroxidase substrate kits (all Vector Laboratories, Burlingame, CA, USA).

    Article Title: Sterile Production of Interferons in the Thymus Impacts T Cell Repertoire Selection
    Article Snippet: For samples using biotinylated antibodies, samples were blocked with the Avidin/Biotin blocking kit following manufacturer protocol (Vector Laboratories).

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
    Article Snippet: They were then treated with their respective biotinylated antibodies; namely, anti-mouse IgG, or anti-rabbit IgG (dilution 1:200; Vector) for 30 min at 25 °C, followed by treatment with avidin–biotin peroxidase complex for 30 min at 25 °C.

    Article Title: Exploring macrophage differentiation and its relation to Modic changes in human herniated disc tissue
    Article Snippet: Subsequently, an avidin-biotin complex technique was performed with the Vectastain ABC-Elite Kit (Vector Lab. USA) and the appropriate biotinylated antibodies.

    Article Title: Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma
    Article Snippet: They were then treated with their respective biotinylated antibodies, namely anti-mouse IgG or anti-rabbit IgG (1:200; Vector) for 30 minutes at 25°C, followed by treatment with avidin-biotin peroxidase complex for 30 minutes at 25°C.

    Article Title: Modulation of GABAergic System in a Chicken Retinal Ischemic Model: The Role of Chloride Cotransporters
    Article Snippet: Anti‐rabbit (cat# BA‐1000, RRID:AB_2313606) and anti‐goat (cat# BA‐5000, RRID:AB_2336126) biotinylated antibodies, and Vectastain Elite ABC‐HRP kit were obtained from Vector Laboratories (Burlingame, CA, USA).



    Similar Products

    96
    Vector Laboratories biotinylated rabbit anti-rat igg antibody, mouse adsorbed
    Biotinylated Rabbit Anti Rat Igg Antibody, Mouse Adsorbed, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/Biotinylated+Rabbit+Anti-Rat+IgG+Antibody%2C+mouse+adsorbed/custom%40ba-4001%4042564426
    Average 96 stars, based on 1 article reviews
    biotinylated rabbit anti-rat igg antibody, mouse adsorbed - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec biotinylated cd45 antibody
    Biotinylated Cd45 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/CD45+Antibody%2C+anti-human%2C+REAfinity/10__3389_slash_fimmu__2026__1844781-106-20-24
    Average 96 stars, based on 1 article reviews
    biotinylated cd45 antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories biotinylated universal antibody (horse anti-mouse/rabbit igg)
    Biotinylated Universal Antibody (Horse Anti Mouse/Rabbit Igg), supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/Biotinylated+Universal+Antibody+(Horse+Anti-Mouse%2FRabbit+IgG)/custom%40ba-1400%4042532140
    Average 96 stars, based on 1 article reviews
    biotinylated universal antibody (horse anti-mouse/rabbit igg) - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories biotinylated goat anti-rabbit igg antibody
    Biotinylated Goat Anti Rabbit Igg Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/Biotinylated+Goat+Anti-Rabbit+IgG+Antibody/custom%40ba-1000%4041807292
    Average 96 stars, based on 1 article reviews
    biotinylated goat anti-rabbit igg antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Vector Laboratories biotinylated secondary antibody
    Biotinylated Secondary Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/Biotinylated+Anti-Avidin+Antibody/pmc13099946-80-7-11
    Average 96 stars, based on 1 article reviews
    biotinylated secondary antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    86
    Mabtech Inc biotinylated anti human ifnγ monoclonal antibody
    Identification of SARS-CoV-2-specific T cell responses by reverse phenotyping (A) CoVa-Adapt study design and sample collection scheme. For all donors, PBMCs were collected at day 0 (P0), 10 days after primary (P10), 10 and 210 days after secondary (S10, S210), and 10 and 189 days after tertiary (T10, T189) vaccination. For selected donors, PBMCs were additionally sampled 108 days after tertiary vaccination (T108, n = 7). Vaccination-induced T cell responses were characterized for most donors on a quantitative level by <t>IFNγ</t> ELISpot. Selected CoVa-Adapt donors were subjected to in-depth characterization using scRNAseq (reverse phenotyping and epitope-specific analyses) followed by TCR functional testing. (B–G) scRNAseq data from the reverse phenotyping dataset. For reverse phenotyping, PBMCs were re-stimulated with 15-mer peptides covering the complete wild-type spike protein or left untreated. Sorted non-naïve CD4 + and/or CD8 + T cells were subjected to scRNAseq. Only CD4 + T cells are shown (annotation described in the methods section). The full dataset is depicted in . (B) UMAP of stimulated (blue) and unstimulated (orange) T cells (left) and Leiden clusters (right; cluster names in UMAP, cluster numbers on the right) ( n = 101,939 cells in total). Cells located within the reactive cluster are displayed with increased point size. (C) Dot plots of log-normalized expression of representative genes per cluster. Selected genes of the reactive cluster are highlighted in gray. Numbers on the left indicate cluster numbers with reactive cluster 12 highlighted in bold. (D and E) IFNG expression (D) and proliferation score (E) in unstimulated (stimulated cells in gray) and stimulated (unstimulated cells in gray) CD4 + T cells (left), and quantification in the stimulated condition of cells in the reactive cluster versus all other clusters (right). Cells located within the reactive cluster are displayed with increased point size. For IFNG , cells with log-normalized gene expression of 0 are shown in gray in UMAPs. Statistical testing by the Mann-Whitney U test. (F) UMAP visualization of cells classified as reactive (cells located in the reactive cluster or belonging to clones where at least one cell is in the reactive cluster) from donor A5 at individual time points after primary (P), secondary (S), and tertiary (T) vaccination in the stimulated condition. Color gradient indicates IFNG expression at the indicated time points. Non-reactive cells and cells from other donors are shown in gray. (G) Fraction of cells from donor A5 at each time point belonging to the reactive cluster. (H and I) Identification of spike-reactive T cells after 20h of in vitro re-stimulation of PBMCs with 15-mer peptides covering the complete wild-type spike protein. Peptides were provided in two subpools, S1 (depicted in H) and S2. Primary data (H) of donor A5 is shown. Quantification (I) of spot-forming units (SFU) for IFNγ ELISpot (combined frequencies of S1 and S2 subpools), data points represent individual donors ( n = 12–19 per time point), solid lines indicate the mean. Samples without SFU above the negative control were set to not detected (n.d.). Donor A5 is highlighted in pink. Statistical testing by the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Significant differences from the P10 time-point are indicated. ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001, n.s. not significant.
    Biotinylated Anti Human Ifnγ Monoclonal Antibody, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/anti+biotinylated+human+ifn%CE%B3+monoclonal/pmc13265900-378-15-22
    Average 86 stars, based on 1 article reviews
    biotinylated anti human ifnγ monoclonal antibody - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Mabtech Inc biotinylated anti human ifn γ
    Identification of SARS-CoV-2-specific T cell responses by reverse phenotyping (A) CoVa-Adapt study design and sample collection scheme. For all donors, PBMCs were collected at day 0 (P0), 10 days after primary (P10), 10 and 210 days after secondary (S10, S210), and 10 and 189 days after tertiary (T10, T189) vaccination. For selected donors, PBMCs were additionally sampled 108 days after tertiary vaccination (T108, n = 7). Vaccination-induced T cell responses were characterized for most donors on a quantitative level by <t>IFNγ</t> ELISpot. Selected CoVa-Adapt donors were subjected to in-depth characterization using scRNAseq (reverse phenotyping and epitope-specific analyses) followed by TCR functional testing. (B–G) scRNAseq data from the reverse phenotyping dataset. For reverse phenotyping, PBMCs were re-stimulated with 15-mer peptides covering the complete wild-type spike protein or left untreated. Sorted non-naïve CD4 + and/or CD8 + T cells were subjected to scRNAseq. Only CD4 + T cells are shown (annotation described in the methods section). The full dataset is depicted in . (B) UMAP of stimulated (blue) and unstimulated (orange) T cells (left) and Leiden clusters (right; cluster names in UMAP, cluster numbers on the right) ( n = 101,939 cells in total). Cells located within the reactive cluster are displayed with increased point size. (C) Dot plots of log-normalized expression of representative genes per cluster. Selected genes of the reactive cluster are highlighted in gray. Numbers on the left indicate cluster numbers with reactive cluster 12 highlighted in bold. (D and E) IFNG expression (D) and proliferation score (E) in unstimulated (stimulated cells in gray) and stimulated (unstimulated cells in gray) CD4 + T cells (left), and quantification in the stimulated condition of cells in the reactive cluster versus all other clusters (right). Cells located within the reactive cluster are displayed with increased point size. For IFNG , cells with log-normalized gene expression of 0 are shown in gray in UMAPs. Statistical testing by the Mann-Whitney U test. (F) UMAP visualization of cells classified as reactive (cells located in the reactive cluster or belonging to clones where at least one cell is in the reactive cluster) from donor A5 at individual time points after primary (P), secondary (S), and tertiary (T) vaccination in the stimulated condition. Color gradient indicates IFNG expression at the indicated time points. Non-reactive cells and cells from other donors are shown in gray. (G) Fraction of cells from donor A5 at each time point belonging to the reactive cluster. (H and I) Identification of spike-reactive T cells after 20h of in vitro re-stimulation of PBMCs with 15-mer peptides covering the complete wild-type spike protein. Peptides were provided in two subpools, S1 (depicted in H) and S2. Primary data (H) of donor A5 is shown. Quantification (I) of spot-forming units (SFU) for IFNγ ELISpot (combined frequencies of S1 and S2 subpools), data points represent individual donors ( n = 12–19 per time point), solid lines indicate the mean. Samples without SFU above the negative control were set to not detected (n.d.). Donor A5 is highlighted in pink. Statistical testing by the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Significant differences from the P10 time-point are indicated. ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001, n.s. not significant.
    Biotinylated Anti Human Ifn γ, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/anti+ifn+%CE%B3/pmc13195792-275-23-25
    Average 86 stars, based on 1 article reviews
    biotinylated anti human ifn γ - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Mabtech Inc anti human ifn γ biotinylated
    Identification of SARS-CoV-2-specific T cell responses by reverse phenotyping (A) CoVa-Adapt study design and sample collection scheme. For all donors, PBMCs were collected at day 0 (P0), 10 days after primary (P10), 10 and 210 days after secondary (S10, S210), and 10 and 189 days after tertiary (T10, T189) vaccination. For selected donors, PBMCs were additionally sampled 108 days after tertiary vaccination (T108, n = 7). Vaccination-induced T cell responses were characterized for most donors on a quantitative level by <t>IFNγ</t> ELISpot. Selected CoVa-Adapt donors were subjected to in-depth characterization using scRNAseq (reverse phenotyping and epitope-specific analyses) followed by TCR functional testing. (B–G) scRNAseq data from the reverse phenotyping dataset. For reverse phenotyping, PBMCs were re-stimulated with 15-mer peptides covering the complete wild-type spike protein or left untreated. Sorted non-naïve CD4 + and/or CD8 + T cells were subjected to scRNAseq. Only CD4 + T cells are shown (annotation described in the methods section). The full dataset is depicted in . (B) UMAP of stimulated (blue) and unstimulated (orange) T cells (left) and Leiden clusters (right; cluster names in UMAP, cluster numbers on the right) ( n = 101,939 cells in total). Cells located within the reactive cluster are displayed with increased point size. (C) Dot plots of log-normalized expression of representative genes per cluster. Selected genes of the reactive cluster are highlighted in gray. Numbers on the left indicate cluster numbers with reactive cluster 12 highlighted in bold. (D and E) IFNG expression (D) and proliferation score (E) in unstimulated (stimulated cells in gray) and stimulated (unstimulated cells in gray) CD4 + T cells (left), and quantification in the stimulated condition of cells in the reactive cluster versus all other clusters (right). Cells located within the reactive cluster are displayed with increased point size. For IFNG , cells with log-normalized gene expression of 0 are shown in gray in UMAPs. Statistical testing by the Mann-Whitney U test. (F) UMAP visualization of cells classified as reactive (cells located in the reactive cluster or belonging to clones where at least one cell is in the reactive cluster) from donor A5 at individual time points after primary (P), secondary (S), and tertiary (T) vaccination in the stimulated condition. Color gradient indicates IFNG expression at the indicated time points. Non-reactive cells and cells from other donors are shown in gray. (G) Fraction of cells from donor A5 at each time point belonging to the reactive cluster. (H and I) Identification of spike-reactive T cells after 20h of in vitro re-stimulation of PBMCs with 15-mer peptides covering the complete wild-type spike protein. Peptides were provided in two subpools, S1 (depicted in H) and S2. Primary data (H) of donor A5 is shown. Quantification (I) of spot-forming units (SFU) for IFNγ ELISpot (combined frequencies of S1 and S2 subpools), data points represent individual donors ( n = 12–19 per time point), solid lines indicate the mean. Samples without SFU above the negative control were set to not detected (n.d.). Donor A5 is highlighted in pink. Statistical testing by the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Significant differences from the P10 time-point are indicated. ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001, n.s. not significant.
    Anti Human Ifn γ Biotinylated, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/anti+ifn+%CE%B3/pmc13195792-5-0-2
    Average 86 stars, based on 1 article reviews
    anti human ifn γ biotinylated - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Mabtech Inc biotinylated anti ifn γ antibodies
    Immunological assessments of the combination of T-mfIL12 and immature BMDCs (A) Immunohistochemical analysis of representative MB49 tumors from the indicated treatment groups. Increased intratumoral infiltration of CD8 + lymphocytes was most prominent in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. In both groups, elevated levels of CD4 + lymphocyte infiltration were also observed in the same tumor sections. Other groups, except for the mock group, showed moderate levels of CD4 + infiltration. Scale bars: 100 μm. (B) ELISpot assay for <t>IFN-γ</t> expression revealed the highest number of IFN-γ-producing splenocytes in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. Monotherapies with BMDC, T-01, or T-mfIL12, as well as the mock group, did not result in significant increases. n = 3 per group; all samples were analyzed in triplicate. Error bars represent standard deviation (SD). ∗ p < 0.05, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Biotinylated Anti Ifn γ Antibodies, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/anti+ifn+%CE%B3/pmc13273829-186-4-8
    Average 86 stars, based on 1 article reviews
    biotinylated anti ifn γ antibodies - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    Vector Laboratories biotinylated horse anti-mouse igg antibody
    Immunological assessments of the combination of T-mfIL12 and immature BMDCs (A) Immunohistochemical analysis of representative MB49 tumors from the indicated treatment groups. Increased intratumoral infiltration of CD8 + lymphocytes was most prominent in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. In both groups, elevated levels of CD4 + lymphocyte infiltration were also observed in the same tumor sections. Other groups, except for the mock group, showed moderate levels of CD4 + infiltration. Scale bars: 100 μm. (B) ELISpot assay for <t>IFN-γ</t> expression revealed the highest number of IFN-γ-producing splenocytes in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. Monotherapies with BMDC, T-01, or T-mfIL12, as well as the mock group, did not result in significant increases. n = 3 per group; all samples were analyzed in triplicate. Error bars represent standard deviation (SD). ∗ p < 0.05, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
    Biotinylated Horse Anti Mouse Igg Antibody, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+biotinylated/Biotinylated+Horse+Anti-Mouse+IgG+Antibody/custom%40ba-2000%4042135530
    Average 96 stars, based on 1 article reviews
    biotinylated horse anti-mouse igg antibody - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    Identification of SARS-CoV-2-specific T cell responses by reverse phenotyping (A) CoVa-Adapt study design and sample collection scheme. For all donors, PBMCs were collected at day 0 (P0), 10 days after primary (P10), 10 and 210 days after secondary (S10, S210), and 10 and 189 days after tertiary (T10, T189) vaccination. For selected donors, PBMCs were additionally sampled 108 days after tertiary vaccination (T108, n = 7). Vaccination-induced T cell responses were characterized for most donors on a quantitative level by IFNγ ELISpot. Selected CoVa-Adapt donors were subjected to in-depth characterization using scRNAseq (reverse phenotyping and epitope-specific analyses) followed by TCR functional testing. (B–G) scRNAseq data from the reverse phenotyping dataset. For reverse phenotyping, PBMCs were re-stimulated with 15-mer peptides covering the complete wild-type spike protein or left untreated. Sorted non-naïve CD4 + and/or CD8 + T cells were subjected to scRNAseq. Only CD4 + T cells are shown (annotation described in the methods section). The full dataset is depicted in . (B) UMAP of stimulated (blue) and unstimulated (orange) T cells (left) and Leiden clusters (right; cluster names in UMAP, cluster numbers on the right) ( n = 101,939 cells in total). Cells located within the reactive cluster are displayed with increased point size. (C) Dot plots of log-normalized expression of representative genes per cluster. Selected genes of the reactive cluster are highlighted in gray. Numbers on the left indicate cluster numbers with reactive cluster 12 highlighted in bold. (D and E) IFNG expression (D) and proliferation score (E) in unstimulated (stimulated cells in gray) and stimulated (unstimulated cells in gray) CD4 + T cells (left), and quantification in the stimulated condition of cells in the reactive cluster versus all other clusters (right). Cells located within the reactive cluster are displayed with increased point size. For IFNG , cells with log-normalized gene expression of 0 are shown in gray in UMAPs. Statistical testing by the Mann-Whitney U test. (F) UMAP visualization of cells classified as reactive (cells located in the reactive cluster or belonging to clones where at least one cell is in the reactive cluster) from donor A5 at individual time points after primary (P), secondary (S), and tertiary (T) vaccination in the stimulated condition. Color gradient indicates IFNG expression at the indicated time points. Non-reactive cells and cells from other donors are shown in gray. (G) Fraction of cells from donor A5 at each time point belonging to the reactive cluster. (H and I) Identification of spike-reactive T cells after 20h of in vitro re-stimulation of PBMCs with 15-mer peptides covering the complete wild-type spike protein. Peptides were provided in two subpools, S1 (depicted in H) and S2. Primary data (H) of donor A5 is shown. Quantification (I) of spot-forming units (SFU) for IFNγ ELISpot (combined frequencies of S1 and S2 subpools), data points represent individual donors ( n = 12–19 per time point), solid lines indicate the mean. Samples without SFU above the negative control were set to not detected (n.d.). Donor A5 is highlighted in pink. Statistical testing by the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Significant differences from the P10 time-point are indicated. ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001, n.s. not significant.

    Journal: iScience

    Article Title: Integrating complementary approaches reveals antigen-reactive CD4 + T cell states after SARS-CoV-2 vaccination

    doi: 10.1016/j.isci.2026.116175

    Figure Lengend Snippet: Identification of SARS-CoV-2-specific T cell responses by reverse phenotyping (A) CoVa-Adapt study design and sample collection scheme. For all donors, PBMCs were collected at day 0 (P0), 10 days after primary (P10), 10 and 210 days after secondary (S10, S210), and 10 and 189 days after tertiary (T10, T189) vaccination. For selected donors, PBMCs were additionally sampled 108 days after tertiary vaccination (T108, n = 7). Vaccination-induced T cell responses were characterized for most donors on a quantitative level by IFNγ ELISpot. Selected CoVa-Adapt donors were subjected to in-depth characterization using scRNAseq (reverse phenotyping and epitope-specific analyses) followed by TCR functional testing. (B–G) scRNAseq data from the reverse phenotyping dataset. For reverse phenotyping, PBMCs were re-stimulated with 15-mer peptides covering the complete wild-type spike protein or left untreated. Sorted non-naïve CD4 + and/or CD8 + T cells were subjected to scRNAseq. Only CD4 + T cells are shown (annotation described in the methods section). The full dataset is depicted in . (B) UMAP of stimulated (blue) and unstimulated (orange) T cells (left) and Leiden clusters (right; cluster names in UMAP, cluster numbers on the right) ( n = 101,939 cells in total). Cells located within the reactive cluster are displayed with increased point size. (C) Dot plots of log-normalized expression of representative genes per cluster. Selected genes of the reactive cluster are highlighted in gray. Numbers on the left indicate cluster numbers with reactive cluster 12 highlighted in bold. (D and E) IFNG expression (D) and proliferation score (E) in unstimulated (stimulated cells in gray) and stimulated (unstimulated cells in gray) CD4 + T cells (left), and quantification in the stimulated condition of cells in the reactive cluster versus all other clusters (right). Cells located within the reactive cluster are displayed with increased point size. For IFNG , cells with log-normalized gene expression of 0 are shown in gray in UMAPs. Statistical testing by the Mann-Whitney U test. (F) UMAP visualization of cells classified as reactive (cells located in the reactive cluster or belonging to clones where at least one cell is in the reactive cluster) from donor A5 at individual time points after primary (P), secondary (S), and tertiary (T) vaccination in the stimulated condition. Color gradient indicates IFNG expression at the indicated time points. Non-reactive cells and cells from other donors are shown in gray. (G) Fraction of cells from donor A5 at each time point belonging to the reactive cluster. (H and I) Identification of spike-reactive T cells after 20h of in vitro re-stimulation of PBMCs with 15-mer peptides covering the complete wild-type spike protein. Peptides were provided in two subpools, S1 (depicted in H) and S2. Primary data (H) of donor A5 is shown. Quantification (I) of spot-forming units (SFU) for IFNγ ELISpot (combined frequencies of S1 and S2 subpools), data points represent individual donors ( n = 12–19 per time point), solid lines indicate the mean. Samples without SFU above the negative control were set to not detected (n.d.). Donor A5 is highlighted in pink. Statistical testing by the Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Significant differences from the P10 time-point are indicated. ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001, n.s. not significant.

    Article Snippet: Plates were washed with PBS containing 0.05% Tween 20 (Sigma-Aldrich, P9416-50 mL) and incubated with biotinylated anti-human IFNγ monoclonal antibody (clone 7-B6-1, Mabtech, 3420-6-250) at 0.2 μg/well for 2 h. Plates were washed a second time with PBS containing 0.05% Tween 20 and subsequently incubated with an avidin-biotinylated peroxidase complex (VECTASTAIN Elite ABC-HRP Kit, Vector Laboratories, VEC-PK-6100) for 1–2 h. Afterward, plates were washed first with PBS containing 0.05% Tween 20 following one washing step with PBS.

    Techniques: Enzyme-linked Immunospot, Functional Assay, Expressing, Gene Expression, MANN-WHITNEY, Clone Assay, In Vitro, Negative Control

    Immunological assessments of the combination of T-mfIL12 and immature BMDCs (A) Immunohistochemical analysis of representative MB49 tumors from the indicated treatment groups. Increased intratumoral infiltration of CD8 + lymphocytes was most prominent in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. In both groups, elevated levels of CD4 + lymphocyte infiltration were also observed in the same tumor sections. Other groups, except for the mock group, showed moderate levels of CD4 + infiltration. Scale bars: 100 μm. (B) ELISpot assay for IFN-γ expression revealed the highest number of IFN-γ-producing splenocytes in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. Monotherapies with BMDC, T-01, or T-mfIL12, as well as the mock group, did not result in significant increases. n = 3 per group; all samples were analyzed in triplicate. Error bars represent standard deviation (SD). ∗ p < 0.05, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Journal: Molecular Therapy Oncology

    Article Title: Induced pluripotent stem cell-derived dendritic cells potentiate the efficacy of interleukin-12-expressing oncolytic HSV-1

    doi: 10.1016/j.omton.2026.201252

    Figure Lengend Snippet: Immunological assessments of the combination of T-mfIL12 and immature BMDCs (A) Immunohistochemical analysis of representative MB49 tumors from the indicated treatment groups. Increased intratumoral infiltration of CD8 + lymphocytes was most prominent in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. In both groups, elevated levels of CD4 + lymphocyte infiltration were also observed in the same tumor sections. Other groups, except for the mock group, showed moderate levels of CD4 + infiltration. Scale bars: 100 μm. (B) ELISpot assay for IFN-γ expression revealed the highest number of IFN-γ-producing splenocytes in the T-mfIL12+BMDC group, followed by the T-01+BMDC group. Monotherapies with BMDC, T-01, or T-mfIL12, as well as the mock group, did not result in significant increases. n = 3 per group; all samples were analyzed in triplicate. Error bars represent standard deviation (SD). ∗ p < 0.05, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

    Article Snippet: Wells were incubated with biotinylated anti-IFN-γ antibodies (R4-6A2; Mabtech AB, cat. #3321-2A) for 2 h at room temperature, followed by a 1-h incubation with the streptavidin-alkaline phosphatase conjugate.

    Techniques: Immunohistochemical staining, Enzyme-linked Immunospot, Expressing, Standard Deviation

    Immunological assessments of the combination of T-mfIL12 and immature iPSDCs (A) Immunohistochemical analysis of representative MB49 tumors from the indicated treatment groups. Increased intratumoral infiltration of CD8 + lymphocytes was observed in both the T-mfIL12+BMDC and T-mfIL12+iPSDC groups. In both groups, CD4 + lymphocyte infiltration was also more prominently observed in the same tumor sections. Other treatment groups, excluding the mock group, exhibited moderate levels of CD4 + T cell infiltration. Scale bars: 100 μm. (B) ELISpot assay showed a high and comparable increase in IFN-γ-producing splenocytes in both the T-mfIL12+BMDC and T-mfIL12+iPSDC groups. n = 3 mice per group; all samples were analyzed in triplicate. Error bars represent standard deviation (SD). ∗∗∗∗ p < 0.0001; NS, not significant.

    Journal: Molecular Therapy Oncology

    Article Title: Induced pluripotent stem cell-derived dendritic cells potentiate the efficacy of interleukin-12-expressing oncolytic HSV-1

    doi: 10.1016/j.omton.2026.201252

    Figure Lengend Snippet: Immunological assessments of the combination of T-mfIL12 and immature iPSDCs (A) Immunohistochemical analysis of representative MB49 tumors from the indicated treatment groups. Increased intratumoral infiltration of CD8 + lymphocytes was observed in both the T-mfIL12+BMDC and T-mfIL12+iPSDC groups. In both groups, CD4 + lymphocyte infiltration was also more prominently observed in the same tumor sections. Other treatment groups, excluding the mock group, exhibited moderate levels of CD4 + T cell infiltration. Scale bars: 100 μm. (B) ELISpot assay showed a high and comparable increase in IFN-γ-producing splenocytes in both the T-mfIL12+BMDC and T-mfIL12+iPSDC groups. n = 3 mice per group; all samples were analyzed in triplicate. Error bars represent standard deviation (SD). ∗∗∗∗ p < 0.0001; NS, not significant.

    Article Snippet: Wells were incubated with biotinylated anti-IFN-γ antibodies (R4-6A2; Mabtech AB, cat. #3321-2A) for 2 h at room temperature, followed by a 1-h incubation with the streptavidin-alkaline phosphatase conjugate.

    Techniques: Immunohistochemical staining, Enzyme-linked Immunospot, Standard Deviation